Myopia Profile Sign in Sign in

Essilor® Stellest®

The Essilor® Stellest® lens with H.A.L.T.* Technology can be considered as a first-line solution for myopia control, with a two-year prospective, controlled, randomized, double-masked trial demonstrating robust efficacy and acceptance in children.1,2 Three-year clinical study data has also been published,3 as well as five-year results.4 It is effective in simultaneously providing clear distance vision and a myopia control effect. The myopia control effect has been proven even more effective when the lenses are worn every day for at least 12 hours per day. It can be considered as one of the best available myopia control spectacle lens designs, being superior to progressive addition and bifocal lenses.

*Highly Aspherical Lenslet Target

Essilor® Stellest® lenses are the first and only FDA market authorized spectacle lens in the United States. They are not commercially available for sale in all countries. 

  1. Bao J, Yang A, Huang Y, Li X, Pan Y, Ding C, Lim EW, Zheng J, Spiegel DP, Drobe B, Lu F, Chen H. One-year myopia control efficacy of spectacle lenses with aspherical lenslets. Br J Ophthalmol. 2022 Aug;106(8):1171-1176.
  2. Bao J, Huang Y, Li X, Yang A, Zhou F, Wu J, et al. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial. JAMA Ophthalmol. 2022 Mar 31;140(5):472–8
  3. Li X, Huang Y, Yin Z, Liu C, Zhang S, Yang A, et al. Myopia Control Efficacy of Spectacle Lenses with Aspherical Lenslets: Results of a 3-year Follow-up Study. Am J Ophthalmol. 2023 Sep;253:160-168.
  4. Li X, Huang Y, Liu C, Chang X, Cui Z, Yang Q, Drobe B, Bullimore MA, Chen H, Bao J. Myopia control efficacy of spectacle lenses with highly aspherical lenslets: results of a 5-year follow-up study. Eye and Vision. 2025 Mar 5;12(1):10.

Visit the Essilor® Stellest® website.

Spectacle lenses
EssilorLuxottica
Essilor® Stellest®
Spectacle lens for myopia correction and control with Highly Aspherical Lenslet Target (H.A.L.T.) Technology
Central optical zone (9 mm⌀) for correcting distance refractive error, with surrounding myopia control zone incorporating 1021 contiguous (touching) highly aspherical lenslets (each 1.12 mm⌀). Each lenslet does not have a single focal power, instead creating a 'volume of myopic defocus' as a slow-down signal for eye growth. Each of the 11 rings of lenslets features contiguous lenslets of similar asphericity, with successive rings having lenslets with different asphericities. Spaces between the rings of lenslets provide single vision correction.
Sphere: plano to -10.00, Cylinder: up to -4.00. Prism up to 2Δ per lens.
Polycarbonate material only, Crizal® coating.
Diameter (65⌀, 70⌀)
With full refraction, taking monocular pupillary distances and monocular heights.
 EL_Logotype_black_1200.pngPlatinum SponsorGlasses(1).svgSpectacles

Essilor® Stellest®.

The ‘hyperopic reserve’ and treatment in pre-myopia - Q&A with Dr Peter ChenPre-myopiaSpectaclesThe ‘hyperopic reserve’ and treatment in pre-myopia - Q&A with Dr Peter ChenDr Peter Chen discusses pre-myopia, hyperopic reserve and approaches for delaying the onset of myopia and managing pre-myopia.Read full article The 6-Year Journey of the Essilor® Stellest® Spectacle Lenses Managing treatment outcomesThe 6-Year Journey of the Essilor® Stellest® Spectacle Lenses Learn more about the 6-year data on the Highly Aspherical Lenslet Target (H.A.L.T.) technology. Read full article Special cases with Essilor® Stellest® lensesSpectaclesSpecial cases with Essilor® Stellest® lensesExploring how Essilor® Stellest® lenses can extend benefits to children with pre-myopia, anisometropia, intermittent exotropia, and retinopathy of prematurity.Read full article Introducing Essilor® Stellest® 2.0 lenses - Q&A with Dr. Björn DrobeSpectaclesGlassesIntroducing Essilor® Stellest® 2.0 lenses - Q&A with Dr. Björn DrobeWe talk to Dr Björn Drobe about the research behind the Essilor® Stellest® 2.0 lens.‡ Read full article EssilorLuxottica at ARVO 2026: key insights in myopia researchSpectaclesPre-myopiaEssilorLuxottica at ARVO 2026: key insights in myopia researchEssilorLuxottica brought new research advancements to ARVO 2026 on Essilor® Stellest® lenses and more. Here's what clinicians need to know.Read full article ARVO2026 Recap #3 – New and improved lens designs & combination therapyCombination treatmentARVO2026 Recap #3 – New and improved lens designs & combination therapyThe third recap from ARVO 2026 highlights next-generation myopia control lens designs and modern approaches to combination therapy.Read full article ARVO2026 Recap #2 – Spectacle lenses under the spotlightSpectaclesARVO2026 Recap #2 – Spectacle lenses under the spotlightThe second recap from ARVO 2026 is all about the latest evidence on spectacle lenses, including Stellest, DOT, MyoCare, and MyCon designs.Read full article Myopic children with intermittent exotropia adapt well to StellestBinocular visionMyopic children with intermittent exotropia adapt well to StellestStellest lenses have minimal effects on binocular vision in myopic children, including those with intermittent exotropia.Read full article Essilor Stellest lenses receive FDA market authorization in the U.S.SpectaclesEssilor Stellest lenses receive FDA market authorization in the U.S.Essilor® Stellest® lenses have received FDA market authorization in the U.S., marking an important milestone for expanding access to spectacle-based myopia management for children.Read full article Three key myopia questions for 2026 Light therapiesAtropineThree key myopia questions for 2026 Atropine 0.01% monotherapy, second generation spectacle lenses and light therapy combo treatments - much to learn!Read full article Boosted asphericity improves efficacy of Essilor Stellest designSpectaclesBoosted asphericity improves efficacy of Essilor Stellest designH.A.L.T. MAX lenses with increased lenslet asphericity slowed eye growth by 0.107 mm more than standard Stellest lenses over 12 months.Read full article HALT lenses with low dose atropine slow myopia progressionSoft contact lensesSpectaclesHALT lenses with low dose atropine slow myopia progressionChildren progressing on low-dose atropine showed reduced axial elongation and refractive change after HALT lenses were added to their treatment.Read full article Defocus lenslet spectacles leave accommodation unchangedMechanismsBinocular visionDefocus lenslet spectacles leave accommodation unchangedStable accommodation with myopia control spectacle lenses suggests other mechanisms drive treatment effects of peripheral opticsRead full article Essilor Stellest lenses effective for pre-myopia with adequate wearPre-myopiaSpectaclesEssilor Stellest lenses effective for pre-myopia with adequate wearEssilor Stellest lenses reduced axial elongation and slowed refractive change in non-myopic Chinese children.Read full article Essilor Stellest lenses reduce axial and peripheral eye elongationSpectaclesEssilor Stellest lenses reduce axial and peripheral eye elongationChildren wearing Stellest lenses showed slower, more symmetrical eye growth compared to single vision lens wearers.Read full article ARVO2025 Recap #1 - Updates in myopia control spectaclesSpectaclesARVO2025 Recap #1 - Updates in myopia control spectaclesThis first recap brings you updates on DIMS, CARE, HALT, and other lens technologies from ARVO 2025. Read full article ARVO2025 Recap #2 - Innovations in optical treatmentsSpectaclesSoft contact lensesARVO2025 Recap #2 - Innovations in optical treatmentsThis second recap is all about emerging spectacle and contact lens technologies from ARVO 2025.Read full article Essilor Stellest lenses: 5-year resultsSpectaclesEssilor Stellest lenses: 5-year results5-year follow-up results of spectacle lenses with highly aspherical lenslets for myopia control provide further long-term efficacy data.Read full article Spectacles with highly aspherical lenslets for pre-myopiaSpectaclesPre-myopiaSpectacles with highly aspherical lenslets for pre-myopiaThis study presents new data on the efficacy of spectacle lenses with highly aspherical lenslets (HAL) in pre-myopic children.Read full article Combining the Essilor® Stellest® lens with atropine – Q&A with Dr Bryan SimAtropineSpectaclesCombining the Essilor® Stellest® lens with atropine – Q&A with Dr Bryan SimWe talk to Dr Bryan Sim about his experience combining the Essilor® Stellest® lens with atropine. Read full article The Essilor® Stellest® Spectacle Lens ARVO 2024 ShowcaseSpectaclesThe Essilor® Stellest® Spectacle Lens ARVO 2024 ShowcaseEssilorLuxottica presented 4 posters at the Association for Research in Vision and Ophthalmology (ARVO) 2024 meeting.Read full article 5 years of the Essilor Stellest - Q&A with Dr. Björn Drobe and Prof. Mark BullimoreSelecting a treatment strategy5 years of the Essilor Stellest - Q&A with Dr. Björn Drobe and Prof. Mark BullimoreDr. Björn Drobe and Professor Mark Bullimore discuss 5-year data on the Essilor® Stellest® lens. Read full article The goal of myopia control: eye growth at emmetropic rates? SpectaclesThe goal of myopia control: eye growth at emmetropic rates? This study evaluates eye growth in myopic children wearing Essilor® Stellest® lenses or single vision lenses (SVL) against non-myopic children.Read full article Highly aspherical lenslet spectacles to single vision and back again: a cross-over studySpectaclesHighly aspherical lenslet spectacles to single vision and back again: a cross-over studyHighly aspherical lenslet (HAL) lenses reduced myopia progression with no rebound effect when children were switched to SV for 6 months.Read full article Myopia control efficacy over three years with highly aspherical lenslet (HAL) spectacle lensesUntreated myopia progressionMyopia control efficacy over three years with highly aspherical lenslet (HAL) spectacle lensesThis study investigated HAL lens efficacy for children who wore for a third year or swapped from single vision of SAL lens designs.Read full article Learning more about the Essilor® Stellest® lensSpectaclesVisual performanceLearning more about the Essilor® Stellest® lensEssilor® Stellest® lens has been shown to effectively reduce the rate of myopic progression. Here's an in-depth dive into the evidence.Read full article Encouraging full time spectacle wear in kidsClinical communicationEncouraging full time spectacle wear in kidsWith myopia controlling spectacles, parents may express concern for accidental breakage when playing sports. What are your recommendations?Read full article Is peripheral vision and reading speed affected by aspherical lenslet spectacle lenses?SpectaclesVisual performanceIs peripheral vision and reading speed affected by aspherical lenslet spectacle lenses?Highly aspherical lenslet spectacle lenses are shown to perform similarly to single vision lenses for peripheral vision and reading speed.Read full article How do different lenslet configurations in myopia control spectacle lenses influence visual performance?SpectaclesVisual performanceHow do different lenslet configurations in myopia control spectacle lenses influence visual performance?This paper examines the effect of lenslet configuration spectacles on the visual performance of young myopes.Read full article Understanding the new Essilor® Stellest® spectacle lensMyopia control efficacyUnderstanding the new Essilor® Stellest® spectacle lensSpectacle lenses which effectively control myopia progression are the next phase in widespread myopia management. Learn more about the Essilor® Stellest® lens.Read full article Myopia control and no rebound with Highly Aspherical Lenslet spectaclesUntreated myopia progressionMyopia control and no rebound with Highly Aspherical Lenslet spectaclesThis randomised, cross-over trial investigated the efficacy of novel spectacles with highly aspheric lenslets.Read full article Two-year clinical trial results of aspherical lenslet spectacles for myopia controlMyopia control efficacyTwo-year clinical trial results of aspherical lenslet spectacles for myopia controlTwo-years of highly aspherical lenslet spectacle lenses slowed myopia by 0.99D and 0.41mm in full-time wearing, 8-13 yr old Chinese children.Read full article The next generation spectacle lenses for myopia controlMyopia control efficacyThe next generation spectacle lenses for myopia controlThe newest myopia controlling spectacles can both correct and control myopia as well as contact lens options. Here we investigate.Read full article One-year myopia control efficacy of spectacle lenses with aspherical lensletsMyopia control efficacyOne-year myopia control efficacy of spectacle lenses with aspherical lensletsA new generation in myopia controlling spectacle lens technology is marked with this one-year clinical data.Read full article When to prescribe spectacles for myopia controlBinocular visionWhen to prescribe spectacles for myopia controlHere we explore an overview of spectacle prescribing for myopia management - when to use single vision, to progressive and bifocals, new designs plus more.Read full article 

EssilorLuxottica resources

Screenshot 2025-03-18 at 6.36.39 AM.png

Five key studies on Essilor® Stellest®

In this new lecture from Dr. Kate Gifford of Myopia Profile, she summarizes five key research studies on Essilor® Stellest® lenses. This concise overview will equip you with essential knowledge for effective myopia management using these lenses. You'll gain insights into their long-term efficacy, eye growth patterns, visual functions, and more. This lecture can also be viewed on Leonardo, the EssilorLuxottica learning ecosystem.

Watch the lecture here